Similarly, enforced suppression of BCL3 by shRNA in DU145 prostate cancer xenografts resulted in a significant reduction in tumour growth which correlated with an increase in the number of cleaved caspase-3 positive cells within the treated tumours but no change in mitotic index [85]. This evidence concerns the gene BCL3 and prostate carcinoma.